Abstract
The use of vancomycin is rapidly increasing due to the emergence of strains of staphylococci resistant to betalactam antibiotics. In this communication the pharmacokinetics of an overdose of vancomycin in a patient during continuous ambulatory peritoneal dialysis (CAPD) is reported. Brainstem auditory evoked potentials (BAEPs) are used to assess ototoxicity. It could be shown that by shortening the dwell time, the apparent CAPD flow was increased and the vancomycin clearance was also increased. This may explain in part the differences in the values of vancomycint 1/2 in this patient (21 h) as compared to other studies (60–120 h). The age of the patient (3.5 years) may also have influenced thet 1/2. Using brainstem auditory evoked potentials as a parameter to assess ototoxicity, it was shown that this patient suffered no damage from the overdose.
References
Kírby WMM. Vancomycin therapy of severe staphylococcal infections. J Antimicrob Chemother 1984; 14(suppl D): 73–8.
Farber BF, Moellering RC. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother 1983; 23: 138–41.
Lau T, Barriere SL. Vancomycin nephrotoxicity. Drug Intell Clin Pharm 1985; 19: 907–8.
Sorrell TC, Collignon PJ. A prospective study of adverse reactions associated with vancomycin therapy. J. Antimicrob Chemother 1985; 16: 235–41.
Bunke CM, Aronoff GR, Brier ME, Sloan RC, Luft FC. Vancomycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983; 34: 631–7.
Magera BE, Arroyo JC, Rosansky SJ, Postic B. Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis. Antimicrob Agents Chemother 1983; 23: 710–4.
Blevins RD, Halstenson CE, Salem NG, Matzke GR. Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1984; 25: 603–6.
Moellering RC. Pharmacokinetics of vancomycin. J Antimicrob Chemother 1984; 14(suppl D): 43–52.
Rogge MC, Johnson CA, Zimmerman SW, Welling PG, Vancomycin disposition during continuous ambulatory peritoneal dialysis: A pharmacokinetic analysis of peritoneal drug transport. Antimicrob Agents Chemother 1985; 27: 578–82.
Matzke GR, Zhanel GG, Guay DRP. Clinical pharmacokinetics of vancomycin. Clin Pharmacokinet 1986; 11: 257–82.
McIntosh ME, Smith WGJ, Forrest G, Brodie MJ. Increased peritoneal permeability in patients with peritonitis undergoing continuous ambulatory peritoneal dialysis. Eur J Clin Pharmacol 1985; 28: 187–91.
Schaad KB, McCracken GH, Nelson JD. Clinical pharmacology and efficacy of vancomycin in pediatric patients. J Pediatr 1980; 96: 119–26.
Cunha BA, Quintiliani R, Deglin JM, Izard MW, Nightingale CH. Pharmacokinetics of vancomycin in anuria. Rev Infect Dis 1981; suppl 3: S269–72.
Pechere JC, Bernard PA, Ferron P, Rouillard R, Picard AC, Murray G. Assessment of minute aminoglycoside ototoxicity by evoked audiometry in humans. In: Periti P, Grassi GG eds. Current Chemotherapy and Immunotherapy. Proceedings of the 12th International Congress of Chemotherapy, Florence, Italy, 19–24, July, 1981. Washington: American Society for Microbiology, 1981: 843–4.
Robert CS. Multisensory evoked potentials in experimental and applied neurotoxicology. Neurobehav Toxicol Teratol 1983; 5: 659–71.
Arezzo JC, Simson R, Bronnan NE. Evoked potentials in the assessment of neurotoxicity in humans. Neurobehav Toxicol Teratol 1985; 7: 299–304.
Kavanagh KT, McCabe BF. Ototoxicity of oral neomycin and vancomycin. Laryngoscope 1983; 93: 649–53.
Rotteveel JJ, Colon EJ, Notermans SLH, Stoelinga GBA, Visco YM, De Graaf R. The central auditory conduction at term date and three months of age. II. Auditory brainstem response. Scand Audiol 1986; 15: 11–9.
Golper T, Bennett W, Jones S. Peritonitis associated with chronic peritoneal dialysis. Dial Transplant 1978; 7: 1173–8.
Janknegt R, Koks CHW. Pharmacokinetic aspects during continuous ambulatory peritoneal dialysis: a literature review. Pharm Weekbl [Sci] 1984; 6: 229–36.
Levey A, Harrington J. Continuous peritoneal dialysis for chronic renal failure. Medicine 1982; 61: 330–9
Matzke GR. Vancomycin. In: Evans E, Schentag JE, Jusko WJ, et al., eds., Applied Pharmacokinetics: principles of therapeutic drug monitoring. 2nd ed. Spokane: Applied Therapeutics Inc., 1986; 399–436.
Eggermont JJ. The inadequacy of click-evoked auditory brainstem responses in audiological applications. Ann NY Acad Sci 1982; 380: 707–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hekster, Y.A., Vree, T.B., Weemaes, C.M.R. et al. Toxicologic and pharmacokinetic evaluation of a case of vancomycin intoxication during continuous ambulatory peritoneal dialysis. Pharmaceutisch Weekblad Scientific Edition 8, 293–297 (1986). https://doi.org/10.1007/BF02280053
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02280053